Healthcare provider profile · identity verified

James E Thompson, MD

Allopathic & Osteopathic Physicians|Family Medicine · BEDFORD, VA · NPI 1023099157

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show James E Thompson, MD received $135.55 in general payments during 2025 across 2 reported records.

Integra LifeSciences Corporation accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 4 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$135.55

2 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Integra LifeSciences Corporation	Unresolved — no canonical attribution shown	$135.55	100.0%	2	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$135.55	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Integra Normalized: integra	Device	Integra LifeSciences Corporation	$135.55	2	2025
Source payment records 2025-03-17 · Integra LifeSciences Corporation · $100.00 · Open Payments source 2025-03-20 · Integra LifeSciences Corporation · $35.55 · Open Payments source
Integra Dermal Regeneration Template Normalized: integra dermal regeneration template	Device	Integra LifeSciences Corporation	$135.55	2	2025
Source payment records 2025-03-17 · Integra LifeSciences Corporation · $100.00 · Open Payments source 2025-03-20 · Integra LifeSciences Corporation · $35.55 · Open Payments source
OMNIGRAFT Normalized: omnigraft	Device	Integra LifeSciences Corporation	$135.55	2	2025
Source payment records 2025-03-17 · Integra LifeSciences Corporation · $100.00 · Open Payments source 2025-03-20 · Integra LifeSciences Corporation · $35.55 · Open Payments source
SURGIMEND Normalized: surgimend	Device	Integra LifeSciences Corporation	$135.55	2	2025
Source payment records 2025-03-17 · Integra LifeSciences Corporation · $100.00 · Open Payments source 2025-03-20 · Integra LifeSciences Corporation · $35.55 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	803	256
Amlodipine Besylate	Amlodipine Besylate	701	225
Lisinopril	Lisinopril	508	156
Losartan Potassium	Losartan Potassium	455	143
Levothyroxine Sodium	Levothyroxine Sodium	415	119
Hydrochlorothiazide	Hydrochlorothiazide	348	116
Omeprazole	Omeprazole	305	95
Pantoprazole Sodium	Pantoprazole Sodium	302	101
Rosuvastatin Calcium	Rosuvastatin Calcium	280	89
Gabapentin	Gabapentin	266	72
Metformin Hcl Er	Metformin Hcl	221	69
Metoprolol Succinate	Metoprolol Succinate	210	75
Albuterol Sulfate Hfa	Albuterol Sulfate	204	66
Pravastatin Sodium	Pravastatin Sodium	201	66
Metformin Hcl	Metformin Hcl	197	64
Furosemide	Furosemide	192	74
Tamsulosin Hcl	Tamsulosin Hcl	181	73
Famotidine	Famotidine	177	68
Metoprolol Tartrate	Metoprolol Tartrate	177	55
Allopurinol	Allopurinol	172	56
Trazodone Hcl	Trazodone Hcl	171	55
Tizanidine Hcl	Tizanidine Hcl	162	69
Meloxicam	Meloxicam	152	51
Sertraline Hcl	Sertraline Hcl	149	49
Alendronate Sodium	Alendronate Sodium	142	49
Simvastatin	Simvastatin	132	43
Eliquis	Apixaban	127	39
Celecoxib	Celecoxib	125	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	120	24
Montelukast Sodium	Montelukast Sodium	120	35
Spironolactone	Spironolactone	112	32
Diclofenac Sodium	Diclofenac Sodium	106	37
Tramadol Hcl	Tramadol Hcl	102	20
Escitalopram Oxalate	Escitalopram Oxalate	100	31
Hydralazine Hcl	Hydralazine Hcl	100	30
Buspirone Hcl	Buspirone Hcl	97	34
Carvedilol	Carvedilol	97	30
Lovastatin	Lovastatin	91	33
Lorazepam	Lorazepam	88	18
Citalopram Hbr	Citalopram Hydrobromide	87	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	81	25
Potassium Chloride	Potassium Chloride	80	29
Duloxetine Hcl	Duloxetine Hcl	78	29
Jardiance	Empagliflozin	78	17
Fluticasone Propionate	Fluticasone Propionate	77	33
Pregabalin	Pregabalin	75	20
Felodipine Er	Felodipine	73	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	73	27
Nystatin	Nystatin	72	26
Prednisone	Prednisone	71	61
Cephalexin	Cephalexin	68	51
Januvia	Sitagliptin Phosphate	68	18
Trulicity	Dulaglutide	68	12
Clopidogrel	Clopidogrel Bisulfate	64	22
Donepezil Hcl	Donepezil Hcl	64	18
Meclizine Hcl	Meclizine Hcl	64	32
Glipizide Er	Glipizide	63	16
Glipizide	Glipizide	62	19
Amitriptyline Hcl	Amitriptyline Hcl	61	21
Benazepril Hcl	Benazepril Hcl	61	17
Atenolol	Atenolol	60	18
Venlafaxine Hcl Er	Venlafaxine Hcl	60	18
Bupropion Xl	Bupropion Hcl	59	25
Fluoxetine Hcl	Fluoxetine Hcl	59	17
Mirtazapine	Mirtazapine	59	18
Alprazolam	Alprazolam	58	suppressed
Clonazepam	Clonazepam	57	11
Glimepiride	Glimepiride	57	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	53	19
Baclofen	Baclofen	49	13
Xarelto	Rivaroxaban	46	14
Farxiga	Dapagliflozin Propanediol	45	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	13
Synthroid	Levothyroxine Sodium	45	12
Triamcinolone Acetonide	Triamcinolone Acetonide	44	21
Mounjaro	Tirzepatide	43	suppressed
Warfarin Sodium	Warfarin Sodium	43	19
Ezetimibe	Ezetimibe	42	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	39	33
Clonidine Hcl	Clonidine Hcl	39	suppressed
Diazepam	Diazepam	39	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	37	28
Ipratropium Bromide	Ipratropium Bromide	37	17
Cefdinir	Cefdinir	36	33
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Breo Ellipta	Fluticasone/Vilanterol	35	suppressed
Ondansetron Odt	Ondansetron	34	20
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	33	suppressed
Fluconazole	Fluconazole	33	21
Propranolol Hcl	Propranolol Hcl	33	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	33	15
Esomeprazole Magnesium	Esomeprazole Magnesium	32	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	14
Estradiol	Estradiol	31	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	31	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	20
Azithromycin	Azithromycin	27	27
Methylprednisolone	Methylprednisolone	27	25
Symbicort	Budesonide/Formoterol Fumarate	27	suppressed
Valsartan	Valsartan	27	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	27	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Methocarbamol	Methocarbamol	25	12
Enalapril Maleate	Enalapril Maleate	24	suppressed
Ozempic	Semaglutide	24	suppressed
Ketoconazole	Ketoconazole	22	suppressed
Risedronate Sodium	Risedronate Sodium	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	22	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	21	suppressed
Klor-Con M10	Potassium Chloride	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Humalog Kwikpen U-100	Insulin Lispro	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Rybelsus	Semaglutide	20	suppressed
Sucralfate	Sucralfate	20	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	19	suppressed
Nitroglycerin	Nitroglycerin	19	14
Amoxicillin	Amoxicillin	18	12
Aripiprazole	Aripiprazole	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	13
Methylphenidate Hcl	Methylphenidate Hcl	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Cilostazol	Cilostazol	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Metronidazole	Metronidazole	17	suppressed
Nortrel	Norethindrone-Ethin. Estradiol	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	16	suppressed
Etodolac	Etodolac	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Finasteride	Finasteride	16	suppressed
Naproxen	Naproxen	16	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Irbesartan	Irbesartan	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Dilt-Xr	Diltiazem Hcl	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Epinephrine	Epinephrine	11	suppressed
Glyburide-Metformin Hcl	Glyburide/Metformin Hcl	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Indomethacin	Indomethacin	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Mili	Norgestimate-Ethinyl Estradiol	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$135.55 · 2 records	Integra LifeSciences Corporation	Integra, Integra Dermal Regeneration Template, OMNIGRAFT, SURGIMEND	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error